---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-071913"
form_type: "8-K"
ticker: "ADPT"
cik: "0001478320"
company_name: "Adaptive Biotechnologies Corp"
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:01:34.725610+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Shareholders elect directors with majority support; Nasdaq confirms audit committee compliance

## Summary
- Peter Neupert elected with 69.15% for (30.85% withhold); Michelle Griffin with 82.93% for.
- Advisory vote on 2023 executive compensation passed with 86% support.
- Ratification of Ernst & Young as independent auditor for FY2024 passed with 99.6% approval.
- Nasdaq confirmed compliance with Listing Rule 5605(c)(2) after Peter Neupert joined audit committee in July 2023.

## SEC filing metadata
- accession: 0000950170-24-071913
- form_type: 8-K
- ticker: ADPT
- cik: 0001478320
- company_name: Adaptive Biotechnologies Corp
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1478320/000095017024071913/0000950170-24-071913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1478320/000095017024071913/adpt-20240607.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-071913
- JSON: https://secwatch.observer/filing/0000950170-24-071913.json
- Plain text: https://secwatch.observer/filing/0000950170-24-071913.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.